Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 9/2011

01-09-2011 | Colorectal Cancer

Young-Onset Rectal Cancer: Presentation, Pattern of Care and Long-term Oncologic Outcomes Compared to a Matched Older-Onset Cohort

Authors: Y. Nancy You, MD, MHSc, Eric J. Dozois, MD, Lisa A. Boardman, MD, Jeremiah Aakre, BS, Marianne Huebner, PhD, David W. Larson, MD

Published in: Annals of Surgical Oncology | Issue 9/2011

Login to get access

Abstract

Background

Recent population-based studies have highlighted a disproportionate increase in the incidence of rectal cancer among adults younger than aged 50 years. To determine whether different intervention and surveillance strategies might be needed for younger patients, the patterns of care and oncologic outcomes among adults younger than aged 50 years with rectal cancer were investigated.

Methods

A cohort of 333 young (<50 years) patients with sporadic rectal cancer was compared to a contemporaneous cohort of 675 older (>65 years) patients for differences in disease pattern, treatments received, and long-term disease-free survival (DFS).

Results

Patient and tumor characteristics did not differ between groups except for an increased presence of signet-ring and mucinous histology in young patients. Younger patients presented with more advanced-stage disease (stages III and IV: 59.4% vs. 46.4%; p = 0.016). More young patients received sphincter-preservation procedures (63.4 vs. 55.4%; p = 0.016), radiation (61.6 vs. 42.1%; p < 0.001), and chemotherapy (67.3 vs. 47.6%; p < 0.001). Fewer young patients were free from recurrent disease at the last follow-up (72.1 vs. 82.5%; p < 0.001). The stage-specific 5-year DFS did not differ between the young and older cohorts. Only stage and the need for chemotherapy independently predicted poor DFS.

Conclusions

Young patients present at a later stage and a greater proportion develop distant disease recurrence over time. However, their stage-specific oncologic outcomes appear similar to those in older-onset patients. To have the greatest impact on long-term oncologic outcomes in patients with young-onset rectal cancer, future interventions should target strategies to diagnosis rectal cancer earlier, and once diagnosed, closer surveillance for recurrence may be warranted.
Literature
1.
2.
Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73.PubMedCrossRef
3.
Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18:1695–8.PubMedCrossRef
4.
Endreseth BH, Romundstad P, Myrvold HE, et al. Rectal cancer in the young patient. Dis Colon Rectum. 2006;49:993–1001.PubMedCrossRef
5.
Boardman LA, Johnson RA, Petersen GM, et al. Higher frequency of diploidy in young-onset microsatellite-stable colorectal cancer. Clin Cancer Res. 2007;13:2323–8.PubMedCrossRef
6.
Fernebro E, Halvarsson B, Baldetorp B, et al (2002) Predominance of CIN versus MSI in the development of rectal cancer at young age. BMC Cancer. 2:25.PubMedCrossRef
7.
Nilbert M, Planck M, Fernebro E, et al. Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer. Eur J Cancer. 1999;35:942–5.PubMedCrossRef
8.
Boardman LA, Schmidt S, Lindor NM, et al. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair. Genes Chromosomes Cancer. 2001;30:181–6.PubMedCrossRef
9.
Riegert-Johnson DL, Johnson RA, Rabe KG, et al. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing. Genet Test. 2007;11:361–5.PubMedCrossRef
10.
Dozois EJ, Boardman LA, Suwanthanma W, et al. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine (Balt). 2008;87:259–63.CrossRef
11.
O’Connell JB, Maggard MA, Livingston EH, et al. Colorectal cancer in the young. Am J Surg. 2004;187:343–8.PubMedCrossRef
12.
O’Connell JB, Maggard MA, Liu JH, et al. Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum. 2004;47:2064–9.PubMedCrossRef
13.
Isbister WH, Fraser J. Large-bowel cancer in the young: a national survival study. Dis Colon Rectum. 1990;33:363–6.PubMedCrossRef
14.
McMillan DC, McArdle CS. The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up. Br J Cancer. 2009;101:557–60.PubMedCrossRef
15.
Griffin PM, Liff JM, Greenberg RS, et al. Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology. 1991;100:1033–40.PubMed
16.
Heys SD, O’Hanrahan TJ, Brittenden J, et al. Colorectal cancer in young patients: a review of the literature. Eur J Surg Oncol. 1994;20:225–31.PubMed
17.
Lee PY, Fletcher WS, Sullivan ES, et al. Colorectal cancer in young patients: characteristics and outcome. Am Surg. 1994;60:607–12.PubMed
18.
O’Connell JB, Maggard MA, Liu JH, et al. Rates of colon and rectal cancers are increasing in young adults. Am Surg. 2003;69:866–72.PubMed
19.
Bleyer A, O’Leary M, Barr R, et al. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. Vol. NIH Pub. No. 06-5767: National Cancer Institute, 2006.
20.
Bulow S. Colorectal cancer in patients less than 40 years of age in Denmark, 1943–1967. Dis Colon Rectum. 1980;23:327–36.PubMedCrossRef
21.
Mitry E, Benhamiche AM, Jouve JL, et al. Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum. 2001;44:380–7.PubMedCrossRef
22.
Nath J, Wigley C, Keighley MR, et al. Rectal cancer in young adults: a series of 102 patients at a tertiary care centre in India. Colorectal Dis. 2009;11:475–9.PubMedCrossRef
23.
Sultan I, Rodriguez-Galindo C, El-Taani H, et al. Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer. 2010;116:758–65.PubMedCrossRef
24.
Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95.PubMedCrossRef
25.
26.
Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol. 2007;14:2759–65.PubMedCrossRef
27.
Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69–77.PubMedCrossRef
28.
Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–8.PubMedCrossRef
29.
Samowitz WS, Curtin K, Wolff RK, et al. Microsatellite instability and survival in rectal cancer. Cancer Causes Control. 2009;20:1763–8.PubMedCrossRef
30.
Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247–57.PubMedCrossRef
31.
Jover R, Zapater P, Castells A, et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer. 2009;45:365–73.PubMedCrossRef
Metadata
Title
Young-Onset Rectal Cancer: Presentation, Pattern of Care and Long-term Oncologic Outcomes Compared to a Matched Older-Onset Cohort
Authors
Y. Nancy You, MD, MHSc
Eric J. Dozois, MD
Lisa A. Boardman, MD
Jeremiah Aakre, BS
Marianne Huebner, PhD
David W. Larson, MD
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 9/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1674-7

Other articles of this Issue 9/2011

Annals of Surgical Oncology 9/2011 Go to the issue

Head and Neck Oncology

Inoperable Symptomatic Recurrent Thyroid Cancers: Preliminary Result of Radiofrequency Ablation

Breast Oncology

Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing Trial

Hepatobiliary Tumors

Significance of Tumor Necrosis for Outcome of Patients with Hepatocellular Carcinoma Receiving Locoregional Therapy Prior to Liver Transplantation

Breast Oncology

Surgical Prevention of Arm Lymphedema After Breast Cancer Treatment

Translational Research and Biomarkers

DNA Repair Gene and MTHFR Gene Polymorphisms as Prognostic Markers in Locally Advanced Adenocarcinoma of the Esophagus or Stomach Treated with Cisplatin and 5-Fluorouracil-Based Neoadjuvant Chemotherapy

Endocrine Tumors

Financial and Clinical Implications of Low-Energy CT Combined with 99mTechnetium-Sestamibi SPECT for Primary Hyperparathyroidism